Insurance companies aren’t the main villain of the U.S. health system
It’s mostly the providers overcharging you, not the middlemen.
Related Articles
House Republicans launch investigation into CVS Caremark for potential antitrust violations
House Republicans want to know whether pharmacy benefit manager (PBM) CVS Caremark violated federal antitrust laws by threatening independent pharmacies to keep them from using…
Zedu Weekly Wrap – 13 December 2024
Our weekly wrap up of the best of the week’s free ultrasound resources – publications, webinars, podcasts, news, views and opinion pieces…
Lurbinectedin is an effective alternative to platinum rechallenge and may restore platinum sensitivity in patients with sensitive relapsed small cell lung cancer
Introduction: Platinum rechallenge is generally recommended for patients with small cell lung cancer (SCLC) who relapse ≥90 days after completing first-line chemotherapy (sensitive relapse); howeve…
Body Weight Gain Associated With Alectinib in Patients With ALK+ Non–Small Cell Lung Cancer: Pooled Analysis of Individual Patient Data From Four Prospective Clinical Trials
PURPOSEWeight gain is a known adverse event (AE) of alectinib. This study evaluates the progression of actual weight gain over time and explores its association…
Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial | JCO Oncology Practice
PURPOSERemote symptom monitoring of patients with cancer has previously shown potential for improving clinical outcomes. This study aimed to evaluate the effects of remote symptom…
Modifiers of risk for infectious complications of cancer therapy in children: The long road ahead
Click on the article title to read more.
Cold acclimation with shivering improves metabolic health in adults with overweight or obesity
Nature Metabolism – Sellers, van Beek and colleagues show that intermittent cold exposure for 10 days, which induced 1 h of shivering per day, improves glucose homeostasis,…
Google Forms: Sign-in
Access Google Forms with a personal Google account or Google Workspace account (for business use).
Nivolumab/Ipilimumab vs Chemotherapy With or Without Targeted Agents in MSI-H or dMMR Metastatic Colorectal Cancer
As reported in The New England Journal of Medicine by Andre et al, interim analysis of the phase III CheckMate 8HW trial has shown that…